IDO1 and hepatocellular carcinoma: Our recent publication has also demonstrated that IDO exhibits a strong correlative expression with PD-L1 in patients with HCC, which suggested that co-blocking of IDO and PD-L1 could be a promising strategy to promote anti-HCC T-cell immunity (Chinnadurai et al., 2020).